miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 1931-1940

  Leung, Carmen O N ^a   Deng, Wen ^a   Ye, Tian Min ^a   Ngan, Hextan Y S ^a   Tsao, Sai Wah ^a   Cheung, Annie N Y ^a   Pang, Ronald T K ^a   Yeung, William S B ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 135A; PROTEIN; PROTEIN E6; PROTEIN E7; PROTEIN P53; SEVEN IN ABSENTIA HOMOLOG 1; SMALL INTERFERING RNA; UBIQUITIN; UNCLASSIFIED DRUG; VIMENTIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CANCER SIZE; CARCINOGENIC ACTIVITY; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL ARTICLE; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMORTALIZED CELL LINE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LASER CAPTURE MICRODISSECTION; LUCIFERASE ASSAY; MALIGNANT TRANSFORMATION; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION; TUMOR XENOGRAFT; UPREGULATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

ANIMALS; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENE EXPRESSION; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84906831740     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu032     Document Type: Article

References (58)

1. Zur Hausen,H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer, 2, 342-350.
2. Walboomers,J.M. et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189, 12-19.
3. Moody,C.A. et al. (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer, 10, 550-560.
4. Koutsky,L. (1997) Epidemiology of genital human papillomavirus infection. Am. J. Med., 102(5A), 3-8.
5. Howlader,N, et al. (2009) SEER Cancer Statistics Review, 1975-2009. National Cancer Institute, Bethesda, MD, USA.
6. Uren,A. et al. (2005) Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res., 65, 6199-6206.
7. Perez-Plasencia,C. et al. (2008) Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway. Int. Arch. Med., 1, 10.
8. Klaes,R. et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res., 59, 6132-6136.
9. Zuna,R.E. et al. (2004) Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod. Pathol., 17, 1314-1322.
10. Krek,A. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
11. Lee,J.W. et al. (2008) Altered MicroRNA expression in cervical carcinomas. Clin. Cancer Res., 14, 2535-2542.
12. Pang,R.T. et al. (2010) MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis, 31, 1037-1044.
13. Wang,X. et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One, 3, e2557.
14. Li,Y. et al. (2011) Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J. Pathol., 224, 484-495.
15. Lui,W.O. et al. (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res., 67, 6031-6043.
16. Nagel,R. et al. (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res., 68, 5795-5802.
17. Liu,S. et al. (2012) MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J. Hepatol., 56, 389-396.
18. Navarro,A. et al. (2009) Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood, 114, 2945-2951.
19. Wu,H. et al. (2012) MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation. Cancer Biol. Ther., 13, 281-288.
20. Schepeler,T. et al. (2012) Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene, 31, 2750-2760.
21. Matsuzawa,S.I. et al. (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell, 7, 915-926.
22. Jang,K.L. et al. (2005) Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc. Natl Acad. Sci. USA, 102, 18431-18436.
23. Liu,J. et al. (2001) Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell, 7, 927-936.
24. Chiu,C.G. et al. (2012) Beta-catenin expression is prognostic of improved non-small cell lung cancer survival. Am. J. Surg., 203, 654-659.
25. Noordhuis,M.G. et al. (2011) Involvement of the TGF-beta and betacatenin pathways in pelvic lymph node metastasis in early-stage cervical cancer. Clin. Cancer Res., 17, 1317-1330.
26. Cheng,Y. et al. (2012) Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma. Hum. Pathol., 43, 1213-1220.
27. Pereira-Suárez,A.L. et al. (2002) Frequent alterations of the beta-catenin protein in cancer of the uterine cervix. Tumour Biol., 23, 45-53.
28. Shinohara,A. et al. (2001) Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol. Oncol., 82, 450-455.
29. Zhou,A.D. et al. (2012) β-Catenin/LEF1 transactivates the micro-RNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway. Oncogene, 31, 2968-2978.
30. Pang,R.T. et al. (2011) miR-135A regulates preimplantation embryo development through down-regulation of E3 ubiquitin ligase seven in absentia homolog 1A (SIAH1A) expression. PLoS One, 6, e27878.
31. Deng,W. et al. (2008) Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells. Cancer Res., 68, 7200-7209.
32. Lee,Y.L. et al. (2001) Establishment and characterization of an immortalized human oviductal cell line. Mol. Reprod. Dev., 59, 400-409.
33. Kim,H.K. et al. (2011) Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection. BMC Med. Genomics, 4, 48.
34. Schmittgen,T.D. et al. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
35. Kishida,S. et al. (2004) Wnt-3a and Dvl induce neurite retraction by activating Rho-associated kinase. Mol. Cell. Biol., 24, 4487-4501.
36. Hiyama,A. et al. (2011) Effects of a glycogen synthase kinase-3β inhibitor (LiCl) on c-myc protein in intervertebral disc cells. J. Cell. Biochem., 112, 2974-2986.
37. Kodithuwakku,S.P. et al. (2011) Hormonal regulation of endometrial olfactomedin expression and its suppressive effect on spheroid attachment onto endometrial epithelial cells. Hum. Reprod., 26, 167-175.
38. Kersemaekers,A.M. et al. (1998) Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br. J. Cancer, 77, 192-200.
39. Shin,S.I. et al. (1975) Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl Acad. Sci. USA, 72, 4435-4439.
40. Confalonieri,S. et al. (2009) Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene, 28, 2959-2968.
41. Rampias,T. et al. (2010) Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol. Cancer Res., 8, 433-443.
42. Kodithuwakku,S.P. et al. (2012) Wnt activation downregulates olfactomedin-1 in Fallopian tubal epithelial cells: a microenvironment predisposed to tubal ectopic pregnancy. Lab. Invest., 92, 256-264.
43. Yoshibayashi,H. et al. (2007) SIAH1 causes growth arrest and apoptosis in hepatoma cells through beta-catenin degradation-dependent and -independent mechanisms. Oncol. Rep., 17, 549-556.
44. Holleman,A. et al. (2011) miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene, 30, 4386-4398.
45. Zhang,Y. et al. (2010) Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma. BMC Cancer, 10, 58.
46. Wu,S. et al. (2012) MiR-135a functions as a selective killer of malignant glioma. Oncogene, 31, 3866-3874.
47. Scheffner,M. et al. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
48. Boyer,S.N. et al. (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res., 56, 4620-4624.
49. Jabbar,S.F. et al. (2012) Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein. Cancer Res., 72, 4008-4016.
50. Jabbar,S.F. et al. (2009) Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene. Cancer Res., 69, 4407-4414.
51. Kravchenko-Balasha,N. et al. (2011) Contribution of gross chromosomal changes to HPV16-induced transformation. Mol. Biosyst., 7, 1501-1511.
52. Steenbergen,R.D. et al. (2005) HPV-mediated transformation of the anogenital tract. J. Clin. Virol., 32(suppl. 1), S25-S33.
53. Zheng,Y. et al. (2013) H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells. Stem Cells Dev., 22, 256-267.
54. Bulut,G. et al. (2011) Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic mice. PLoS One, 6, e27243.
55. Didiano,D. et al. (2006) Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat. Struct. Mol. Biol., 13, 849-851.
56. Wotschofsky,Z. et al. (2011) Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal. Biochem., 417, 233-241.
57. Li,Y. et al. (2010) High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia. J. Int. Med. Res., 38, 1730-1736.
58. Gee,H.E. et al. (2011) The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br. J. Cancer, 104, 1168-1177.